Rare cancers

Rare cancers

Theme leader: Carla van Herpen

Despite the rarity of each of the 186 rare cancers (i.e. incidence <6/100,000), they represent in total about 22% of all cancer cases. Examples are head and neck cancer, sarcoma, thyroid cancer, neuroendocrine cancer, brain tumors, lymphoma, and pediatric cancer. They pose particular challenges due to their low frequency, including (i) late or incorrect diagnosis; (ii) lack of access to appropriate therapies and clinical expertise; (iii) a very limited number of clinical trials due to the small number of patients; (iv) lack of interest in the development of new therapies due to limitations in the market; (v) few available registries and tissue banks. Our mission is to improve diagnosis and prognosis for this patient group in an (inter)national collaborative setting.

 

Theme news

More items

Next theme events

Nov 23 - Nov 23
Radboud Research Rounds Plus: Prof. Guy ThwaitesImproving outcomes from severe infectious diseases: where’s the evidence?
Nov 9 - Nov 9

Related assistant / associate / full professors

Blijlevens, Nicole
Blijlevens, NicoleThe research focus on personalized supportive care in hematology patients is targeted to stem cell transplant recipients.   read more >>
Bussink, Jan
Bussink, Jan  read more >>
Bram_van_Ginneken.jpg
van Ginneken, Bram  read more >>
Graaf Van Der, Winette
van der Graaf, WinetteBringing preclinical findings from the lab to the clinic and vice versa  read more >>
Herpen, Carla van
van Herpen, CarlaMore than 4 million people in the European Union are affected by rare cancers. Despite the rarity of each of the 186 rare cancers, they represent in total about 22% of all cancer cases. This is more than any single common cancer. Rare cancers are identified as those with an incidence of less than 6 per 100,000 persons per year. Examples of rare cancer are head and neck cancer, sarcoma, thyroid cancer, neuroendocrine cancer, brain tumors, lymphoma, and pediatric cancer. Unfortunately, the average outcome for patients with a rare cancer is inferior to those with more common cancers. Rare cancers pose particular challenges due to their low frequency, including: 1 Late or incorrect diagnosis 2 Lack of access to appropriate therapies and clinical expertise 3 A very limited number of clinical trials due to the small number of patients 4 Lack of interest in the development of new therapies due to limitations in the market 5 Few available registries and tissue banks Our mission is to improve diagnosis and prognosis, to perform (personalized) clinical studies and translational research - from bench to bedside – in patients with rare cancer. This will be performed in relationship with patients advocacy groups, if applicable. Given the rarity of the tumors collaboration with (inter)national centers and partners is vital for the success of this theme.  read more >>
Kaanders , Hans
Kaanders, Hans  read more >>
Marres , Henri
Marres, Henri  read more >>
Merkx , Thijs
Merkx, Thijs  read more >>
Oyen , Wim
Oyen, Wim  read more >>
Speksnijder , Caroline
Speksnijder, Caroline  read more >>
Stevens - Kroef, Marian
Stevens-Kroef, Marian  read more >>
Takes, Robert
Takes, Robert  read more >>
Wesseling, Pieter
Wesseling, PieterMolecular and cellular dissection of tumour micro-environment interactions in brain tumours.  read more >>